PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS

Compounds of Formula I that inhibit Btk are described herein. Pharmaceutical compositions comprising at least one compound of Formula I, together with at least one pharmaceutically acceptable vehicle chosen from carriers, adjuvants, and excipients, are described. Methods of treating patients sufferi...

Full description

Saved in:
Bibliographic Details
Main Authors BLOMGREN, Peter, A, ORTWINE, Daniel, ZHAO, Zhongdong, YOUNG, Wendy, B, LEE, Seung, H, BARBOSA, Antonio, J., Jr, RENNELLS, William, M, CURRIE, Kevin, S, XU, Jianjun, ZHICHKIN, Pavel, E, SCHMITT, Aaron, C, KROPF, Jeffrey, E, MITCHELL, Scott, A
Format Patent
LanguageEnglish
French
German
Published 21.03.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula I that inhibit Btk are described herein. Pharmaceutical compositions comprising at least one compound of Formula I, together with at least one pharmaceutically acceptable vehicle chosen from carriers, adjuvants, and excipients, are described. Methods of treating patients suffering from certain diseases responsive to inhibition of Btk activity and/or B-cell activity are described. Methods for determining the presence of Btk in a sample are described.
Bibliography:Application Number: EP20090752681